nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—CHRM2—type 1 diabetes mellitus	0.912	1	CbGaD
Brompheniramine—Dimetindene—CHRM2—type 1 diabetes mellitus	0.00132	0.325	CrCbGaD
Brompheniramine—Tolterodine—CHRM2—type 1 diabetes mellitus	0.00114	0.282	CrCbGaD
Brompheniramine—Diphenhydramine—CHRM2—type 1 diabetes mellitus	0.000567	0.14	CrCbGaD
Brompheniramine—Orphenadrine—CHRM2—type 1 diabetes mellitus	0.000536	0.132	CrCbGaD
Brompheniramine—Promazine—CHRM2—type 1 diabetes mellitus	0.000489	0.121	CrCbGaD
Brompheniramine—CHRM5—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.42e-05	0.000289	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.41e-05	0.000288	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	2.41e-05	0.000288	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—HBA1—type 1 diabetes mellitus	2.4e-05	0.000287	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	2.39e-05	0.000286	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—APOC3—type 1 diabetes mellitus	2.39e-05	0.000285	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—HBA1—type 1 diabetes mellitus	2.35e-05	0.000281	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.35e-05	0.000281	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—GSTT1—type 1 diabetes mellitus	2.34e-05	0.00028	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.34e-05	0.00028	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—APOC3—type 1 diabetes mellitus	2.34e-05	0.00028	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.33e-05	0.000279	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.33e-05	0.000279	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.33e-05	0.000279	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.33e-05	0.000278	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.33e-05	0.000278	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.32e-05	0.000277	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.32e-05	0.000277	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.31e-05	0.000276	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.3e-05	0.000275	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.3e-05	0.000275	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—GSTT1—type 1 diabetes mellitus	2.3e-05	0.000275	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—TYK2—type 1 diabetes mellitus	2.29e-05	0.000274	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.29e-05	0.000273	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—KCNJ11—type 1 diabetes mellitus	2.28e-05	0.000273	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	2.24e-05	0.000267	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	2.23e-05	0.000266	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CCR5—type 1 diabetes mellitus	2.22e-05	0.000266	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.2e-05	0.000263	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CD86—type 1 diabetes mellitus	2.2e-05	0.000263	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CCR5—type 1 diabetes mellitus	2.2e-05	0.000263	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—TYK2—type 1 diabetes mellitus	2.2e-05	0.000263	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.2e-05	0.000263	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.19e-05	0.000262	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.19e-05	0.000262	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—GCG—type 1 diabetes mellitus	2.17e-05	0.00026	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.17e-05	0.000259	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ITPR3—type 1 diabetes mellitus	2.16e-05	0.000258	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	2.13e-05	0.000255	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CD86—type 1 diabetes mellitus	2.11e-05	0.000252	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—IL2—type 1 diabetes mellitus	2.1e-05	0.000251	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	2.1e-05	0.000251	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—E2F1—type 1 diabetes mellitus	2.09e-05	0.00025	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—KCNJ11—type 1 diabetes mellitus	2.08e-05	0.000249	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SST—type 1 diabetes mellitus	2.05e-05	0.000245	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SST—type 1 diabetes mellitus	2.04e-05	0.000244	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.04e-05	0.000244	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SST—type 1 diabetes mellitus	2.04e-05	0.000244	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.03e-05	0.000243	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—HBA1—type 1 diabetes mellitus	2.03e-05	0.000243	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.03e-05	0.000242	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—APOC3—type 1 diabetes mellitus	2.02e-05	0.000242	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SST—type 1 diabetes mellitus	2.02e-05	0.000241	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—IL2—type 1 diabetes mellitus	2.01e-05	0.000241	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.01e-05	0.00024	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	2e-05	0.00024	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—E2F1—type 1 diabetes mellitus	2e-05	0.000239	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.98e-05	0.000237	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—GSTT1—type 1 diabetes mellitus	1.98e-05	0.000237	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.95e-05	0.000233	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ITPR3—type 1 diabetes mellitus	1.93e-05	0.000231	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.92e-05	0.00023	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.91e-05	0.000228	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.9e-05	0.000227	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.87e-05	0.000224	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—GCG—type 1 diabetes mellitus	1.87e-05	0.000223	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.84e-05	0.00022	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—CAT—type 1 diabetes mellitus	1.84e-05	0.00022	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—GCG—type 1 diabetes mellitus	1.83e-05	0.000219	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.83e-05	0.000219	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.83e-05	0.000219	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—GCG—type 1 diabetes mellitus	1.83e-05	0.000218	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—GCG—type 1 diabetes mellitus	1.82e-05	0.000218	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—GCG—type 1 diabetes mellitus	1.81e-05	0.000217	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—HBA1—type 1 diabetes mellitus	1.81e-05	0.000217	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—APOC3—type 1 diabetes mellitus	1.8e-05	0.000216	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—GCG—type 1 diabetes mellitus	1.8e-05	0.000215	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	1.77e-05	0.000212	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GSTT1—type 1 diabetes mellitus	1.77e-05	0.000212	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.76e-05	0.00021	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	1.76e-05	0.00021	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.75e-05	0.00021	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.75e-05	0.000209	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	1.74e-05	0.000208	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.73e-05	0.000207	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.71e-05	0.000204	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.7e-05	0.000204	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.7e-05	0.000204	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.7e-05	0.000203	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.7e-05	0.000203	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.69e-05	0.000202	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.68e-05	0.000201	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.68e-05	0.0002	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	1.67e-05	0.0002	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	1.66e-05	0.000198	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	1.65e-05	0.000198	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	1.64e-05	0.000197	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.63e-05	0.000195	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	1.63e-05	0.000195	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	1.61e-05	0.000193	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CD80—type 1 diabetes mellitus	1.61e-05	0.000192	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—GCG—type 1 diabetes mellitus	1.58e-05	0.000189	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CAT—type 1 diabetes mellitus	1.58e-05	0.000189	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.55e-05	0.000186	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CAT—type 1 diabetes mellitus	1.55e-05	0.000185	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.55e-05	0.000185	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.55e-05	0.000185	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.54e-05	0.000184	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.54e-05	0.000184	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CD80—type 1 diabetes mellitus	1.54e-05	0.000184	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.54e-05	0.000184	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.53e-05	0.000183	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.52e-05	0.000182	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—INS—type 1 diabetes mellitus	1.52e-05	0.000181	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CD86—type 1 diabetes mellitus	1.49e-05	0.000178	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.49e-05	0.000178	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CD86—type 1 diabetes mellitus	1.48e-05	0.000178	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CD86—type 1 diabetes mellitus	1.48e-05	0.000177	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.47e-05	0.000176	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CD86—type 1 diabetes mellitus	1.47e-05	0.000175	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.46e-05	0.000175	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—INS—type 1 diabetes mellitus	1.45e-05	0.000174	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.42e-05	0.00017	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.42e-05	0.00017	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.41e-05	0.000169	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.41e-05	0.000169	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GCG—type 1 diabetes mellitus	1.41e-05	0.000169	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.41e-05	0.000168	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.41e-05	0.000168	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.4e-05	0.000168	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.4e-05	0.000167	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.4e-05	0.000167	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.39e-05	0.000166	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	1.37e-05	0.000164	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.36e-05	0.000162	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.34e-05	0.000161	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.34e-05	0.00016	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CAT—type 1 diabetes mellitus	1.34e-05	0.00016	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.33e-05	0.00016	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.33e-05	0.000159	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.32e-05	0.000158	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.32e-05	0.000158	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.32e-05	0.000157	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.31e-05	0.000157	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.3e-05	0.000156	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.3e-05	0.000155	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.3e-05	0.000155	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	1.3e-05	0.000155	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.3e-05	0.000155	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.29e-05	0.000155	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.29e-05	0.000154	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.29e-05	0.000154	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	1.29e-05	0.000154	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.28e-05	0.000153	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.28e-05	0.000153	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.27e-05	0.000152	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.27e-05	0.000152	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—INS—type 1 diabetes mellitus	1.22e-05	0.000146	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CAT—type 1 diabetes mellitus	1.19e-05	0.000143	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	1.16e-05	0.000139	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.13e-05	0.000135	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL2—type 1 diabetes mellitus	1.13e-05	0.000135	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.12e-05	0.000134	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—ALB—type 1 diabetes mellitus	1.12e-05	0.000134	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	1.1e-05	0.000131	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	1.09e-05	0.00013	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	1.09e-05	0.00013	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CD80—type 1 diabetes mellitus	1.09e-05	0.00013	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	1.08e-05	0.00013	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	1.08e-05	0.000129	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.08e-05	0.000129	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL2—type 1 diabetes mellitus	1.08e-05	0.000129	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CD80—type 1 diabetes mellitus	1.08e-05	0.000129	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.07e-05	0.000129	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—NOS3—type 1 diabetes mellitus	1.07e-05	0.000128	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CD80—type 1 diabetes mellitus	1.07e-05	0.000128	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	1.06e-05	0.000127	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—INS—type 1 diabetes mellitus	1.05e-05	0.000125	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—INS—type 1 diabetes mellitus	1.03e-05	0.000123	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—INS—type 1 diabetes mellitus	1.03e-05	0.000123	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—INS—type 1 diabetes mellitus	1.02e-05	0.000122	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—INS—type 1 diabetes mellitus	1.02e-05	0.000122	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—INS—type 1 diabetes mellitus	1.01e-05	0.000121	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.93e-06	0.000119	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.9e-06	0.000118	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.88e-06	0.000118	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.86e-06	0.000118	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.85e-06	0.000118	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.82e-06	0.000117	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.77e-06	0.000117	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.72e-06	0.000116	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—ALB—type 1 diabetes mellitus	9.62e-06	0.000115	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—STAT3—type 1 diabetes mellitus	9.49e-06	0.000114	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ALB—type 1 diabetes mellitus	9.42e-06	0.000113	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—NOS3—type 1 diabetes mellitus	9.2e-06	0.00011	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.17e-06	0.00011	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.14e-06	0.000109	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.11e-06	0.000109	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—STAT3—type 1 diabetes mellitus	9.09e-06	0.000109	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.02e-06	0.000108	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—NOS3—type 1 diabetes mellitus	9.01e-06	0.000108	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NOS3—type 1 diabetes mellitus	9e-06	0.000108	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.97e-06	0.000107	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.94e-06	0.000107	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—INS—type 1 diabetes mellitus	8.88e-06	0.000106	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.86e-06	0.000106	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—EGFR—type 1 diabetes mellitus	8.63e-06	0.000103	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	8.48e-06	0.000101	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—EGFR—type 1 diabetes mellitus	8.26e-06	9.88e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ALB—type 1 diabetes mellitus	8.14e-06	9.74e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—INS—type 1 diabetes mellitus	7.93e-06	9.48e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—NOS3—type 1 diabetes mellitus	7.79e-06	9.32e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.64e-06	9.14e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL2—type 1 diabetes mellitus	7.63e-06	9.13e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.62e-06	9.11e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	7.61e-06	9.1e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.59e-06	9.08e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.59e-06	9.08e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL2—type 1 diabetes mellitus	7.58e-06	9.07e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.57e-06	9.05e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.54e-06	9.02e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.52e-06	8.99e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL2—type 1 diabetes mellitus	7.51e-06	8.98e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.47e-06	8.93e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	7.29e-06	8.72e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ALB—type 1 diabetes mellitus	7.27e-06	8.69e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	7.23e-06	8.65e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	7.18e-06	8.59e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—NOS3—type 1 diabetes mellitus	6.95e-06	8.32e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	6.69e-06	8e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL6—type 1 diabetes mellitus	6.63e-06	7.93e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	6.63e-06	7.93e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.42e-06	7.68e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.4e-06	7.65e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	6.39e-06	7.65e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.38e-06	7.63e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL6—type 1 diabetes mellitus	6.35e-06	7.59e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	6.34e-06	7.58e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.32e-06	7.56e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.84e-06	6.98e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.82e-06	6.96e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.8e-06	6.93e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.74e-06	6.87e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	4.77e-06	5.7e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL6—type 1 diabetes mellitus	4.48e-06	5.36e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	4.47e-06	5.35e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL6—type 1 diabetes mellitus	4.46e-06	5.33e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL6—type 1 diabetes mellitus	4.41e-06	5.28e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	4.37e-06	5.23e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	4.18e-06	5e-05	CbGpPWpGaD
